SELLAS Life Sciences (SLS) Change in Account Payables (2010 - 2026)
SELLAS Life Sciences (SLS) reported Change in Account Payables of $685000.0 for Q1 2026, up 147.29% year-over-year from $277000.0 in Q1 2025, and up 3.79% on a QoQ basis from $660000.0 in Q4 2025.
SELLAS Life Sciences (SLS) has 17 years of Change in Account Payables data on file, last reported at $685000.0 in Q1 2026.
- Quarterly Change in Account Payables rose 147.29% year-over-year to $685000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$127000.0 (up 96.54% YoY) and the FY2025 annual result came in at -$535000.0, up 74.99% from the prior year.
- Change in Account Payables climbed to $685000.0 in Q1 2026 per SLS's latest filing, from $660000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.8 million in Q1 2024 and bottomed at -$1.8 million in Q3 2024.
- The 5-year median for Change in Account Payables is $528000.0 (2022), against an average of $89705.9.
- The widest annual swing landed in 2022, when Change in Account Payables tumbled 550.56%; it then surged 735.92% in 2024.
- Tracing SLS's Change in Account Payables over 5 years: stood at $1.2 million in 2022, then advanced by 7.15% to $1.3 million in 2023, then plunged by 184.83% to -$1.1 million in 2024, then soared by 159.03% to $660000.0 in 2025, then rose by 3.79% to $685000.0 in 2026.
- Per Business Quant, the three latest SLS Change in Account Payables figures stand at $685000.0 (Q1 2026), $660000.0 (Q4 2025), and -$1.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -3.26 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 35.60 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | 685,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 685,000.00 |
| Mar 31, 2026 | 685,000.00 |
| Dec 31, 2025 | 660,000.00 |
| Dec 31, 2025 | 660,000.00 |
| Sep 30, 2025 | -1.03 Mn |
| Sep 30, 2025 | -1.03 Mn |
| Jun 30, 2025 | -441,000.00 |
| Jun 30, 2025 | -441,000.00 |
| Mar 31, 2025 | 277,000.00 |
| Mar 31, 2025 | 277,000.00 |
| Dec 31, 2024 | -1.12 Mn |
| Dec 31, 2024 | -1.12 Mn |
| Sep 30, 2024 | -1.77 Mn |
| Sep 30, 2024 | -1.77 Mn |
| Jun 30, 2024 | -1.06 Mn |
| Jun 30, 2024 | -1.06 Mn |
| Mar 31, 2024 | 1.81 Mn |
| Mar 31, 2024 | 1.81 Mn |
| Dec 31, 2023 | 1.32 Mn |
| Dec 31, 2023 | 1.32 Mn |
| Sep 30, 2023 | 606,000.00 |
| Sep 30, 2023 | 606,000.00 |
| Jun 30, 2023 | 661,000.00 |
| Jun 30, 2023 | 661,000.00 |
| Mar 31, 2023 | -284,000.00 |
| Mar 31, 2023 | -284,000.00 |
| Dec 31, 2022 | 1.23 Mn |
| Dec 31, 2022 | 1.23 Mn |
| Sep 30, 2022 | -1.21 Mn |
| Sep 30, 2022 | -1.21 Mn |
| Jun 30, 2022 | 528,000.00 |
| Jun 30, 2022 | 528,000.00 |
| Mar 31, 2022 | 667,000.00 |
| Mar 31, 2022 | 667,000.00 |
| Dec 31, 2021 | -401,000.00 |
| Dec 31, 2021 | -401,000.00 |
| Sep 30, 2021 | 269,000.00 |
| Sep 30, 2021 | 269,000.00 |
| Jun 30, 2021 | -1.48 Mn |
| Jun 30, 2021 | -1.48 Mn |
| Mar 31, 2021 | -897,000.00 |
| Mar 31, 2021 | -897,000.00 |
| Dec 31, 2020 | 1.29 Mn |
| Dec 31, 2020 | 1.29 Mn |
| Sep 30, 2020 | -647,000.00 |
| Sep 30, 2020 | -647,000.00 |
| Jun 30, 2020 | -173,000.00 |
| Jun 30, 2020 | -173,000.00 |
| Mar 31, 2020 | -1.30 Mn |
| Mar 31, 2020 | -1.30 Mn |
| Dec 31, 2019 | 239,000.00 |
| Dec 31, 2019 | 239,000.00 |
| Sep 30, 2019 | 36,000.00 |
| Sep 30, 2019 | 36,000.00 |
| Jun 30, 2019 | -1.15 Mn |
| Jun 30, 2019 | -1.15 Mn |
| Mar 31, 2019 | 883,000.00 |
| Mar 31, 2019 | 883,000.00 |
| Dec 31, 2018 | -3.48 Mn |
| Dec 31, 2018 | -3.48 Mn |
| Sep 30, 2018 | -4.86 Mn |
| Sep 30, 2018 | -4.86 Mn |
| Jun 30, 2018 | 648,000.00 |
| Jun 30, 2018 | 648,000.00 |
| Mar 31, 2018 | -240,000.00 |
| Mar 31, 2018 | -240,000.00 |
| Dec 31, 2017 | 7.99 Mn |
| Dec 31, 2017 | 7.99 Mn |
| Sep 30, 2017 | 680,000.00 |
| Sep 30, 2017 | 680,000.00 |
| Jun 30, 2017 | -3.89 Mn |
| Jun 30, 2017 | -3.89 Mn |
| Mar 31, 2017 | 3.59 Mn |
| Mar 31, 2017 | 3.59 Mn |
| Dec 31, 2016 | 24.24 Mn |
| Dec 31, 2016 | 24.24 Mn |
| Sep 30, 2016 | -24.68 Mn |
| Sep 30, 2016 | -24.68 Mn |
| Jun 30, 2016 | 254,000.00 |
| Jun 30, 2016 | 254,000.00 |
| Mar 31, 2016 | -578,000.00 |
| Mar 31, 2016 | -578,000.00 |
| Dec 31, 2015 | 359,000.00 |
| Dec 31, 2015 | 359,000.00 |
| Sep 30, 2015 | 177,000.00 |
| Sep 30, 2015 | 177,000.00 |
| Jun 30, 2015 | -850,000.00 |
| Jun 30, 2015 | -850,000.00 |
| Mar 31, 2015 | 25,000.00 |
| Mar 31, 2015 | 25,000.00 |
| Dec 31, 2014 | -75,000.00 |
| Dec 31, 2014 | -75,000.00 |
| Sep 30, 2014 | 678,000.00 |
| Sep 30, 2014 | 678,000.00 |
| Jun 30, 2014 | 462,000.00 |
| Jun 30, 2014 | 462,000.00 |
| Mar 31, 2014 | -1.09 Mn |
| Mar 31, 2014 | -1.09 Mn |
| Dec 31, 2013 | 17,000.00 |
| Dec 31, 2013 | 17,000.00 |
| Sep 30, 2013 | -202,000.00 |
| Sep 30, 2013 | -202,000.00 |
| Jun 30, 2013 | -31,000.00 |
| Jun 30, 2013 | -31,000.00 |
| Mar 31, 2013 | 147,000.00 |
| Mar 31, 2013 | 147,000.00 |
| Dec 31, 2012 | -234,000.00 |
| Dec 31, 2012 | -234,000.00 |
| Sep 30, 2012 | 504,000.00 |
| Sep 30, 2012 | 504,000.00 |
| Jun 30, 2012 | -55,000.00 |
| Jun 30, 2012 | -55,000.00 |
| Mar 31, 2012 | 426,000.00 |
| Mar 31, 2012 | 426,000.00 |
| Dec 31, 2011 | 693,000.00 |
| Dec 31, 2011 | 693,000.00 |
| Sep 30, 2011 | 397,000.00 |
| Sep 30, 2011 | 397,000.00 |
| Jun 30, 2011 | -592,000.00 |
| Jun 30, 2011 | -592,000.00 |
| Mar 31, 2011 | 2,000.00 |
| Mar 31, 2011 | 2,000.00 |
| Dec 31, 2010 | -112,000.00 |
| Dec 31, 2010 | -112,000.00 |
| Sep 30, 2010 | 507,000.00 |
| Sep 30, 2010 | 507,000.00 |